Associations between amyloid β and white matter hyperintensities: A systematic review
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Introduction: This systematic review synthesizes current evidence for associations between cortical amyloid β, visualized on amyloid positron emission tomography imaging, and white matter hyperintensity (WMH) burden on magnetic resonance imaging in healthy elderly adults and individuals with cognitive impairment and dementia. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) systematic review guidelines, we systematically searched MEDLINE, Embase, Cochrane, and PsycINFO databases from January 2000 to September 2015. Results: Our search returned 492 articles, 34 of which met criteria for inclusion in the final selection. Most studies reported no significant relationships between amyloid β and WMH burden across diagnostic groups. Discussion: Findings of this systematic review suggest that amyloid accumulation and WMH are independent but additive processes. The limited number of independent cohorts, lack of longitudinal data, and exclusion of individuals with mixed dementia limit the generalizability of these findings. Further studies are required to elucidate the putative contributions of vascular processes to neurodegenerative pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Secreted Aβ can oligomerise, induce inflammation and aggregate into potentially toxic amyloid plaques [27,28], while p3 is not known to be neurotoxic.”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 1×
“In vivo imaging of amyloid pathology is an important tool, as amyloid often accumulates in prodromal stages before symptoms appear [61,77], and the exact mechanisms leading to its deposition are not fully understood.”
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citationReprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & and the PRISMA Group (2009) · Physical Therapy · doi:10.1093/ptj/89.9.873 · Cited by 2,486
Debette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328
Clearance systems in the brain—implications for Alzheimer disease
Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., Axel, L., Rusinek, H., Nicholson, C., Zlokovic, B. V., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.119 · Cited by 1,678
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986
Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement
Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., Blazer, D. G., Chen, C., Chui, H., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000034 · Cited by 852
Self-citationPike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789
Coon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., Zismann, V. L., Beach, T. G., Leung, D., Bryden, L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0419 · Cited by 569
Lee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24647 · Cited by 542 · cited 1×
“Understanding anymoderating effects ofAPOE ε4 is of particular importance in understanding the accumulation of amyloid, as prior work has shown that parieto-occipital increases in WMH volume are apparent 22 years before symptom onset and amyloid is seen on PET imaging up to 15 years before the onset of symptoms [66,67…”
Klunk, W. E., Wang, Y., Huang, G.-F., Debnath, M. L., Holt, D. P., & Mathis, C. A. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01232-2 · Cited by 457
Brain β-amyloid load approaches a plateau
Jack, C. R., Wiste, H. J., Lesnick, T. G., Weigand, S. D., Knopman, D. S., Vemuri, P., Pankratz, V. S., Senjem, M. L., Gunter, J. L., Mielke, M. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840bbe · Cited by 406
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
Benzinger, T. L. S., Blazey, T., Jack, C. R., Koeppe, R. A., Su, Y., Xiong, C., Raichle, M. E., Snyder, A. Z., Ances, B. M., Bateman, R. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317918110 · Cited by 391
Provenzano, F. A., Muraskin, J., Tosto, G., Narkhede, A., Wasserman, B. T., Griffith, E. Y., Guzman, V. A., Meier, I. B., Zimmerman, M. E., Brickman, A. M., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1321 · Cited by 192
Brain injury biomarkers are not dependent on β‐amyloid in normal elderly
Knopman, D. S., Jack, C. R., Wiste, H. J., Weigand, S. D., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23816 · Cited by 183
Identification of pure subcortical vascular dementia using 11 C-Pittsburgh compound B
Lee, J. H., Kim, S. H., Kim, G. H., Seo, S. W., Park, H. K., Oh, S. J., Kim, J. S., Cheong, H. K., & Na, D. L. (2011) · Neurology · doi:10.1212/wnl.0b013e318221acee · Cited by 179
Wirth, M., Villeneuve, S., Haase, C. M., Madison, C. M., Oh, H., Landau, S. M., Rabinovici, G. D., & Jagust, W. J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4013 · Cited by 171
Incidence of cerebral microbleeds in preclinical Alzheimer disease
Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000285 · Cited by 150 · cited 3×
“Individuals with cognitive impairment or dementia had significantly higher ratios of amyloid uptake than normal control subjects [23,31,33], and individuals with AD had significantly higher uptake than those with MCI [31,33].”
InfluentialCerebrovascular disease, beta-amyloid, and cognition in aging
Marchant, N. L., Reed, B. R., DeCarli, C. S., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.001 · Cited by 127 · cited 6×
“R o seb o ro u g h et a l. / A lzh eim er’s & D em en tia 1 3 (2 0 1 7 ) 1 1 5 4 -1 1 6 7 1 1 5 8 NC (27) Unknown Cross-sectional Population based 35.70 Cluster analysis to define high vs. low groups Rating Scale Sojkova et al. 2008 [25] NC (393) Unknown Longitudinal (2.7 y) Community based 34 .1.5 SUVR Volumetric Vem…”
InfluentialDecline in intelligence is associated with progression in white matter hyperintensity volume
Garde, E. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.055905 · Cited by 118
Lack of association between prior depressive episodes and cerebral [11C]PiB binding
Madsen, K., Hasselbalch, B. J., Frederiksen, K. S., Haahr, M. E., Gade, A., Law, I., Price, J. C., Knudsen, G. M., Kessing, L. V., & Hasselbalch, S. G. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.021 · Cited by 66
Research works printed but not linked: 58
- Alzheimer's Disease International, 2014, World Alzheimer Report 2014: dementia and risk reduction an analysis of protective and modifiable factors
- 10.1212/WNL.45.11.2077 · DOI · Paper page
- 10.1002/ana.20630 · DOI · Paper page
- 10.1016/S1474-4422(10)70104-6 · DOI · Paper page
- 10.1016/j.jalz.2006.09.002 · DOI
- Villeneuve S, 2015, Imaging vascular disease and amyloid in the aging brain: implications for treatment, J Prev Alzheimers Dis, 2, 64
- 10.1016/S1474-4422(13)70124-8 · DOI · Paper page
- 10.1159/000083801 · DOI
- 10.1136/jnnp.67.1.66 · DOI · Paper page
- Bowen BC, 1990, MR signal abnormalities in memory disorder and dementia, AJNR Am J Neuroradiol, 11, 283
- 10.2214/ajr.149.2.351 · DOI · Paper page
- 10.1016/0197-4580(95)00021-6 · DOI · Paper page
- 10.1002/ana.20009 · DOI · Paper page
- 10.1016/j.neurobiolaging.2012.01.016 · DOI
- 10.1016/j.nicl.2015.04.017 · DOI
- 10.1016/j.ijsu.2014.07.013 · DOI · Paper page
- 10.1016/j.neulet.2015.03.005 · DOI
- 10.1212/WNL.0000000000000977 · DOI
- 10.2967/jnumed.108.051946 · DOI
- 10.1093/brain/awu393 · DOI · Paper page
- 10.1212/01.wnl.0000435301.64776.37 · DOI · Paper page
- Villeneuve S, 2014, Cortical thickness mediates the effect of beta‐amyloid on episodic memory, Neurology, 82, 761, 10.1212/WNL.0000000000000170 · DOI
- 10.1002/ana.23830 · DOI · Paper page
- 10.1212/WNL.0b013e3182815485 · DOI
- 10.1016/j.jalz.2014.04.521 · DOI
- 10.1111/ene.12645 · DOI
- Kim HJ, 2013, Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis, PLoS One, 8, 1
- 10.1212/WNL.0000000000000360 · DOI
- 10.3233/JAD-130461 · DOI · Paper page
- 10.1016/j.neurobiolaging.2013.06.026 · DOI
- 10.1002/ana.23845 · DOI · Paper page
- 10.1016/j.jstrokecerebrovasdis.2013.08.004 · DOI
- 10.1016/j.neurobiolaging.2013.01.002 · DOI
- 10.1016/j.neurobiolaging.2013.05.009 · DOI
- 10.1001/2013.jamaneurol.405 · DOI · Paper page
- Ortner M, 2015, Small vessel disease, but neither amyloid load nor metabolic deficit, is dependent on age at onset in Alzheimer's disease, Biol Pyschiatry, 77, 704, 10.1016/j.biopsych.2014.01.019 · DOI · Paper page
- 10.1002/jmri.24550 · DOI
- 10.1038/jcbfm.2010.135 · DOI
- Gurol EM, 2012, Cerebral amyloid angiopathy independently contributes to ischemic white matter disease: a PET/MRI correlative study, Ann Neurol, 72, S43
- 10.1016/j.jns.2012.04.014 · DOI
- 10.1111/ene.12376 · DOI
- 10.1016/j.neurobiolaging.2014.02.015 · DOI
- 10.1212/WNL.0000000000000550 · DOI
- 10.1212/WNL.0000000000002352 · DOI
- 10.1002/ana.10161 · DOI · Paper page
- 10.2967/jnumed.109.065284 · DOI · Paper page
- 10.1111/j.1750-3639.2008.00133.x · DOI · Paper page
- 10.1371/journal.pcbi.1003956 · DOI · Paper page
- 10.1016/j.neurobiolaging.2011.10.002 · DOI
- Kuller L, 2013, Arterial stiffness is associated with amyloid deposition in the brain independent of blood pressure, Alzheimers Dement, 1, P543
- 10.3233/JAD-150862 · DOI
- 10.1016/j.jad.2015.08.032 · DOI
- 10.1016/j.jalz.2014.07.155 · DOI
- MHabes GErus JBToledo TZhang NBryan LJLauner et al.White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain2016;1164–1179 · DOI · Paper page
- 10.1016/j.neurobiolaging.2015.08.026 · DOI
- 10.1111/ijs.12615 · DOI
- 10.1111/bpa.12218 · DOI · Paper page
- 10.1038/jcbfm.2015.85 · DOI
Cited by
Cerebral small vessel disease: from a focal to a global perspective
ter Telgte, A., van Leijsen, E. M. C., Wiegertjes, K., Klijn, C. J. M., Tuladhar, A. M., & de Leeuw, F.-E. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0014-y · Cited by 541
Alber, J., Alladi, S., Bae, H., Barton, D. A., Beckett, L. A., Bell, J. M., Berman, S. E., Biessels, G. J., Black, S. E., Bos, I., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.02.001 · Cited by 443
Self-citationEnhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer’s disease
Chen, J.-F., Liu, K., Hu, B., Li, R.-R., Xin, W., Chen, H., Wang, F., Chen, L., Li, R.-X., Ren, S.-Y., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.012 · Cited by 346
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 305
Rabin, J. S., Schultz, A. P., Hedden, T., Viswanathan, A., Marshall, G. A., Kilpatrick, E., Klein, H., Buckley, R. F., Yang, H.-S., Properzi, M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1123 · Cited by 221
Metadata
- Authors
- Roseborough, A., Ramirez, J., Black, S. E., & Edwards, J. D.
- Affiliations
- LC Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2017-03-16
- Volume
- 13
- Issue
- 10
- Pages
- 1154-1167
- ISSN
- 1552-5260
- 1552-5279
- Cited by
- 127
- References
- 23
- Language
- en
- Funders
- Sunnybrook Research Institute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.